Physician profile

Marcy Lim Lim

Cardiovascular Disease · Humble, TX

NPI 1578671392

$32,336.64

in general payments reported to CMS, 2019-2025

39 companies · $907 in 2025

The $907 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,886.20

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic Vascular, INC. $25,856.62 2019
Abbott Laboratories $1,581.81 2019-2025 Aveir, Assurity, Ensite Precision
Bard Peripheral Vascular, INC. $465.80 2019-2022
Janssen Pharmaceuticals, INC $361.64 2019-2024 Xarelto
Novartis Pharmaceuticals Corporation $352.71 2019-2025
Cvrx, INC. $259.97 2021-2024 Barostim Neo System
Pfizer INC. $258.03 2020-2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $247.58 2020-2025 Lifevest
Boston Scientific Corporation $244.16 2019-2025 Watchman Flx, Watchman Access System
Heartflow, INC. $237.43 2022-2025
E.R. Squibb & Sons, L.L.C. $204.04 2019-2024 Camzyos, Eliquis
Kestra Medical Technology Services, INC. $201.19 2025 Assure Wcd
Amarin Pharma, INC. $196.50 2019-2021
Impulse Dynamics (USA) INC. $179.24 2021-2022
Amgen INC. $174.07 2019-2024 Repatha
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $161.34 2019-2025 Jardiance
Esperion Therapeutics, INC. $153.11 2021-2024 Nexletol
Astellas Pharma US INC $152.88 2019-2021
Astrazeneca Pharmaceuticals LP $123.40 2020-2025 Farxiga, Wainua
Alnylam Pharmaceuticals INC. $117.76 2021-2022
Merck Sharp & Dohme LLC $102.35 2021-2024 Verquvo, Januvia
Canon Medical Systems USA, INC. $98.83 2023 Pet-Ct Scanner
Bolton Medical INC $65.63 2020
Regeneron Pharmaceuticals, INC. $64.92 2019-2025 Evkeeza
Atricure, INC. $62.05 2022
Medtronic, INC. $55.59 2022-2025 Symplicity G3
Novo Nordisk INC $54.45 2024-2025 Rybelsus, Ozempic, Wegovy
Tactile Systems Technology INC $51.17 2021-2022
Infobionic, INC $36.24 2020
Biosense Webster, INC. $34.11 2023 Carto 3
Regeneron Healthcare Solutions, INC. $32.50 2019
Resmed Corp $25.09 2022
Cardiovascular Systems INC. $25.00 2020
Bayer Healthcare Pharmaceuticals INC. $21.10 2025
Azurity Pharmaceuticals, INC. $19.20 2025 Edarbi
Althera Pharmaceuticals LLC $17.36 2021
Scpharmaceuticals INC. $17.32 2025
Kowa Pharmaceuticals America, INC. $13.31 2020
Arbor Pharmaceuticals, INC. $11.14 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Marcy Lim Lim

$32,336.64

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic Vascular, INC.
Context
The $907 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/253521/marcy-lim-lim

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.